That at least some of these genes are relevant to human cancer is supported by a recent report that high STAG3 expression in colorectal cancer is associated with metastasis, drug resistance, and poor clinical outcomes (Sasaki et al., 2021). This evidence concerns the gene STAG3 and colorectal cancer.